Biodesix to Participate in Upcoming Investor Conferences
Biodesix (NASDAQ: BDSX), a diagnostic solutions company, has announced its participation in two upcoming investor conferences. The company will attend the 22nd Annual Craig-Hallum Institutional Investor Conference for one-on-one meetings on May 28, 2025, in Minneapolis, MN. Additionally, Biodesix will present at the 45th Annual William Blair Growth Stock Conference on June 4, 2025, at 9:20 AM CT in Chicago, IL. The William Blair conference presentation will be available via webcast and can be accessed through the Investors section of Biodesix's website under "News & Events".
Biodesix (NASDAQ: BDSX), azienda specializzata in soluzioni diagnostiche, ha annunciato la sua partecipazione a due prossimi convegni per investitori. La società sarà presente al 22° Annuale Craig-Hallum Institutional Investor Conference per incontri individuali il 28 maggio 2025 a Minneapolis, MN. Inoltre, Biodesix presenterà al 45° Annuale William Blair Growth Stock Conference il 4 giugno 2025 alle 9:20 AM CT a Chicago, IL. La presentazione al convegno William Blair sarà disponibile in webcast e potrà essere seguita nella sezione Investitori del sito web di Biodesix, sotto la voce "News & Events".
Biodesix (NASDAQ: BDSX), una empresa de soluciones diagnósticas, ha anunciado su participación en dos próximas conferencias para inversores. La compañía asistirá a la 22ª Conferencia Anual Craig-Hallum Institutional Investor para reuniones individuales el 28 de mayo de 2025 en Minneapolis, MN. Además, Biodesix presentará en la 45ª Conferencia Anual William Blair Growth Stock el 4 de junio de 2025 a las 9:20 AM CT en Chicago, IL. La presentación en la conferencia William Blair estará disponible vía webcast y podrá accederse a ella a través de la sección de Inversores en la página web de Biodesix, bajo "Noticias y Eventos".
Biodesix (NASDAQ: BDSX)는 진단 솔루션 회사로서, 다가오는 두 개의 투자자 컨퍼런스에 참여할 예정임을 발표했습니다. 회사는 2025년 5월 28일 미네소타주 미니애폴리스에서 열리는 제22회 Craig-Hallum 기관 투자자 연례 컨퍼런스에서 일대일 미팅에 참석합니다. 또한, Biodesix는 2025년 6월 4일 오전 9시 20분(중부시간) 일리노이주 시카고에서 개최되는 제45회 William Blair 성장주 연례 컨퍼런스에서 발표할 예정입니다. William Blair 컨퍼런스 발표는 웹캐스트로 제공되며, Biodesix 웹사이트의 투자자 섹션 내 "뉴스 및 이벤트"에서 시청할 수 있습니다.
Biodesix (NASDAQ : BDSX), une entreprise spécialisée dans les solutions diagnostiques, a annoncé sa participation à deux prochaines conférences pour investisseurs. La société assistera à la 22e conférence annuelle Craig-Hallum Institutional Investor pour des réunions individuelles le 28 mai 2025 à Minneapolis, MN. De plus, Biodesix présentera lors de la 45e conférence annuelle William Blair Growth Stock le 4 juin 2025 à 9h20 CT à Chicago, IL. La présentation lors de la conférence William Blair sera disponible en webcast et accessible via la section Investisseurs du site web de Biodesix, sous "Actualités & Événements".
Biodesix (NASDAQ: BDSX), ein Unternehmen für diagnostische Lösungen, hat seine Teilnahme an zwei bevorstehenden Investorenkonferenzen bekanntgegeben. Das Unternehmen wird am 22. jährlichen Craig-Hallum Institutional Investor Conference am 28. Mai 2025 in Minneapolis, MN, für Einzelgespräche teilnehmen. Zusätzlich wird Biodesix am 45. jährlichen William Blair Growth Stock Conference am 4. Juni 2025 um 9:20 Uhr CT in Chicago, IL, präsentieren. Die Präsentation auf der William Blair Konferenz wird per Webcast verfügbar sein und kann über den Bereich "Investoren" auf der Biodesix-Website unter "News & Events" abgerufen werden.
- None.
- None.
LOUISVILLE, Colo., May 21, 2025 (GLOBE NEWSWIRE) -- Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostic solutions company, today announced that members of the Biodesix management team, will participate in two upcoming investor conferences:
22nd Annual Craig-Hallum Institutional Investor Conference
1x1 Meetings
Date: Wednesday, May 28, 2025
Location: Minneapolis, MN
45th Annual William Blair Growth Stock Conference
Presentation and 1x1 Meetings
Date and Time: Wednesday, June 4, 2025 at 9:20 AM CT
Location: Chicago, IL
The presentation will be webcast live and available for replay under “News & Events” in the Investors section of the Company's website at biodesix.com.
About Biodesix
Biodesix is a leading diagnostic solutions company, driven to improve clinical care and outcomes for patients. Biodesix Diagnostic Tests, marketed as Nodify Lung® Nodule Risk Assessment and IQLung™ Cancer Treatment Guidance, support clinical decisions to expedite personalized care and improve outcomes for patients with lung disease. Biodesix Development Services enable the world’s leading biopharmaceutical, life sciences, and research institutions with scientific, technological, and operational capabilities that fuel the development of diagnostic tests, tools, and therapeutics. For more information, visit biodesix.com.
Trademarks: Biodesix, Biodesix Logo, Nodify Lung, and IQLung are trademarks or registered trademarks of Biodesix, Inc.
Contacts:
Media:
Natalie St. Denis
Natalie.StDenis@biodesix.com
1-720-925-9285
Investors:
Chris Brinzey
chris.brinzey@icrhealthcare.com
1-339-970-2843
FAQ
When is Biodesix (BDSX) presenting at the William Blair Growth Stock Conference 2025?
Where can I watch Biodesix's (BDSX) William Blair conference presentation?
Which investor conferences is Biodesix (BDSX) attending in 2025?
When is Biodesix (BDSX) participating in the Craig-Hallum Conference 2025?
